Clickbait Style Titles
-Lose Weight and Fight Diabetes with the Click of a Button: Introducing LillyDirect
-Can’t Lose Weight? The Eli Lilly Website That Might Have the Answer
-The Incredible New Service From Eli Lilly That Can Help You Lose Weight Quickly
-Say Goodbye to Stubborn Weight – Meet LillyDirect From Eli Lilly
-Diabetes and Weight Loss Treatment Now Available from Leading Drug Maker Eli Lilly
Rewritten Content
Eli Lilly, a leading drugmaker, has launched LillyDirect, a groundbreaking website for telehealth prescribing of weight loss drugs. The site is the first of its kind from a pharmaceutical company and enables doctors to provide access to GLP-1 agonist drugs, such as Lilly’s Zepbound and Mounjaro and Novo Nordisk’s Ozempic and Wegovy.
Eligible for Telehealth on LillyDirect
Patients prescribed Zepbound via LillyDirect will have the unique benefit of at-home delivery service. Healthcare providers can prescribe any FDA-approved medication for weight loss, however only those using Lilly’s service will be eligible for the delivery service, as announced by Eli Lilly’s CEO David Ricks in a statement to NBC News.
In order to qualify for enrollment on the website, patients must possess a BMI of at least 30 or a BMI of at least 27 along with at least one weight-related medical condition. The website is open to those who have diabetes or migraines as well.
A Quick Fix or Long-Term Solution?
Several other sites, such as Weight Watchers, Noom and Found, also currently provide online access to the popular generic drug – semaglutide, but LillyDirect is the first service from a pharmaceutical company.
While there is a temptation to view these weight loss drugs as a quick fix, Eli Lilly and Novo Nordisk have both stated that it is more of a long-term solution geared toward those with serious weight issues. For example, a study conducted by the Mayo Clinic in 2022 showed that patients given weekly semaglutide injections over the course of 6 months lost 27 pounds on average.
Accessibility and Costs
Affordability is a huge issue for many patients, as one month’s supply of injectable weight loss drugs can cost over $1,000. Fortunately, drug manufacturers are hoping to increase accessibility by pushing for insurance coverage. In 2021, a surge in sales of semaglutide drugs drove up the stock prices of Eli Lilly and Novo Nordisk to record-highs.
Dangers and Side Effects
The widespread use of medications in the GLP-1 agonist class has been widely criticized by certain scientists and former users. Lab studies have revealed a possible link between the drugs and thyroid tumors in rodents, as noted by the Mayo Clinic, while there is still much to learn about the long-term effects of using semaglutide. Lawsuits over the drugs have been brought against Novo Nordisk and Eli Lilly due to the claims that they can lead to gastroparesis, a severe stomach disorder.
TikTok influencer, Remi Bader, and actress Amy Schumer have both come forward to speak about their experiences of severe weight gain after their use of the medications was discontinued. Bader has expressed that her former medication made her binge eating “so much worse”, while Schumer has spoken out about feeling “so ill” while taking her weight loss medication.
Lose Weight and Fight Diabetes with the Click of a Button: Introducing LillyDirect
Eli Lilly, a leading drugmaker, has launched LillyDirect, the first of its kind pharmaceutical website for telehealth prescribing of weight loss drugs. The new service is a one-stop-shop for individuals who are looking to lose weight or gain an edge in the fight against diabetes.
Overview of LillyDirect
The website provides access to GLP-1 agonist drugs, such as Lilly’s Zepbound and Mounjaro and Novo Nordisk’s Ozempic and Wegovy. In order to qualify, patients must possess a BMI of at least 30 or a BMI of at least 27 along with at least one weight-related medical condition. The website is open to those who have diabetes or migraines as well.
The website can be used by doctors to prescribe any FDA-approved weight loss drug, but only those prescribed Zepbound will have access to the exclusive at-home delivery service mentioned by Eli Lilly’s CEO in a statement to NBC News.
A Quick Fix or Long-Term Solution?
While there is a temptation to view these medications as a quick fix, Eli Lilly and Novo Nordisk have both stated that using these drugs should be seen as a long-term solution geared toward individuals with serious weight issues. For example, a study conducted by the Mayo Clinic in 2022 showed that patients given weekly semaglutide injections over the course of 6 months lost 27 pounds on average.
Accessibility and Costs
A month’s supply of injectable weight loss drugs can cost patients more than $1,000 when it is not covered by insurance. In response to this, drug manufacturers are pushing for more insurance providers to offer coverage of such medications. This push has been met with wild success, as the stocks of Eli Lilly and Novo Nordisk both hit record highs in August of 2021 following a surge in sales.
Dangers and Side Effects
Using GLP-1 agonist drugs has been heavily criticized by some scientists and former users. Research has linked these medications to thyroid tumors in rodents, according to the Mayo Clinic, and the long-term effects of the drugs are still largely unknown. The manufacturers of Ozempic and Mounjaro, Novo Nordisk and Eli Lilly, were sued this summer over claims the medications can cause gastroparesis.
Finally, several influencers, including TikTok star Remi Bader and actress Amy Schumer, have been vocal about the side effects of stopping the medication – in both cases, they experienced a significant increase in weight even after discontinuing the use of the drugs. This highlights the importance of speaking with your doctor before taking any form of treatment for weight loss.
